MedPath

Exploring Mechanistic Study: Potential of Luseogliflozin on Restoration of Cardiomyocyte Energy Metabolism in Diabetic Patients with Coronary Artery Disease

Not Applicable
Conditions
Type 2 Diabetes
Registration Number
JPRN-UMIN000037291
Lead Sponsor
Kumamoto University
Brief Summary

Case registration did not proceed, and it was judged that it would be difficult to carry out the research using the protocol at the time of application.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

1. Type 1 diabetes 2. Unstable angina 3. 3-vessel disease 4. insulin usage 5. eGFR < 45ml/min/1.73m2 6. Liver failure (Child-Pugh: Type C) 7. Severe Heart failure (NYHA Stage4) 8. BMI <18.5kg/m2 9. Allergic reaction to drugs 10. Pregnant, breastfeeding patients or suspected patients 11. Patients with malignant diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes of blood metabolic profiles
Secondary Outcome Measures
NameTimeMethod
Change of diastolic dysfunction
© Copyright 2025. All Rights Reserved by MedPath